British Ambassador to Yemen: The West Has Forgotten the Reason of War

British Ambassador to Yemen Michael Aron (Asharq Al-Awsat)
British Ambassador to Yemen Michael Aron (Asharq Al-Awsat)
TT

British Ambassador to Yemen: The West Has Forgotten the Reason of War

British Ambassador to Yemen Michael Aron (Asharq Al-Awsat)
British Ambassador to Yemen Michael Aron (Asharq Al-Awsat)

The newly-appointed British Ambassador to Yemen, Michael Aron, said that the public opinion in the West has forgotten the reason that had started the war because of the worsening humanitarian crisis.

Stressing the deployment of strenuous efforts to alleviate the sufferings of the Yemeni population, Aron noted that the war started with a coup perpetrated by a small group of Yemenis, in reference to Houthi militias, adding that there was no need for an Iranian role in Yemen.

The ambassador said he believed that efforts initiated by the new UN Special Envoy, Martin Griffiths, would yield “real results to resolve the Yemeni crisis this year,” adding that the envoy would travel to Sanaa and Aden this week to listen to the opinion of the different sides before returning to New York to attend a Security Council session on April 17 and meet with UN Secretary General Antonio Guterres.

On the Saudi role, Aron said: “I think it was clear in the visit of the Saudi Crown Prince Mohammed bin Salman to Britain that the Saudis want a solution to the problem and, in my opinion, the Saudi role is very important in this regard as Saudi Arabia supports the solution and the political process but cannot accept to live under the threat of ballistic missiles from a neighboring country.”

“They also want security along their borders, and they reject any role for Iran in Yemen and we support them in all these concerns, and it is very important to agree on these matters,” he added.

Asked about the guarantees that would make the militias accept a new peace initiative, especially with the outcome of the Kuwait negotiations, where the legitimate government signed the international peace agreement and offered many compromises, while the Houthis rejected the agreement, the British ambassador stressed that Yemenis living in areas controlled by Houthis would not accept the continuation of war.

“So I believe that with the efforts of the Special Envoy and the help of the international community, the problem can be solved this year,” Aron stated.

He emphasized that the Yemeni file was a priority for the British government, which he said was helping the UN efforts and the special envoy.

He noted that Griffiths, of British nationality, was an independent employee who has been appointed to assume this post due to his technical expertise.

“We support his efforts… I am optimistic and I think the opportunities in the coming months are real and not just words,” Aron said.

The British ambassador presented an overview of his country’s humanitarian support to Yemen.

He said that during the 2017-2018 fiscal year, Britain has offered 205 Million GBP in aid, which makes the country the second largest donor of financial aid.

He also underlined British support to the efforts of the United Nations, expressing satisfaction with the appointment of Lise Grande as the new UN humanitarian coordinator in Sanaa.

“We are working with the Coalition and neighboring countries to bring aid through the port of Hodeidah. I believe that easing sanctions on the Houthis could be a confidence-building step and would allow the distribution of aid to all Yemenis without any sanctions from both sides,” Aron noted.

The British ambassador highly valued the humanitarian plan launched by Saudi Arabia to support the Yemeni people and the central bank. He also praised efforts deployed by the Yemeni legitimate forces, backed by the Coalition, to fight terrorism on Yemeni territories.

Asked about Iran’s negative role in Yemen, Aron said: “I do not think there is a need for an Iranian role in Yemen. I spoke to the Yemenis and they do not want any role for Iran in their country. The relationship between the Houthis and Iran is new, and is not welcome by Yemenis.”

“So if the Iranians say they want peace in the region and Yemen and they are sincere in that, they should withdraw and stop their military assistance to the Houthis, which is an important part of solving the problem,” he stated.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.